Fig. 5: In vivo differentiation potential of WT and GCM1-KO TS^Term cells.

NOD-SCID mice were subcutaneously injected with TS^Term#2 (a, b) or TS#2^GCM1-KO#6 (c) cells for 10 days. Sections of TS^Term#2 and TS#2^GCM1-KO#6 cell-derived lesions were subjected to hematoxylin and eosin (HE) staining and immunostaining of CK7, hCGβ, and HLA-G. Scale bar, 100 μm.